FDA Inspection
Charles River Laboratories, Inc.Charles River Laboratories, Inc. – FDA Inspection, Feb 11, 2020
Record Details
This FDA Inspection record concerns Charles River Laboratories, Inc., with an inspection on February 11, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 11, 2020
- Product Type
- Drugs
View Company Profile
ID · fa1747ef-a2df-4569-b810-a35e36454cce
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1118068
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.46(b)Equipment for Environmental Control
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Charles River Laboratories, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 9, 2025 | VAI | New England District Office | Drug Quality Assurance |
| May 2, 2025 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 21, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 12, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Charles River Laboratories, Inc.
- FDA Inspection 1281548 - 2025-09-09
- FDA Inspection 1271053 - 2025-05-02
- FDA Inspection 1015411 - 2017-06-21
- FDA Inspection 889473 - 2014-06-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.